Nature Cancer· 2026Q1
An iron-regulated methionine redox axis governs adipose browning and cancer cachexia
- 1citations
- Q1SCImago
- 2026year
Short summary
An iron-dependent pathway, where iron activates methionine sulfoxide reductase A (MSRA) to reverse methionine oxidation, drives adipose browning and cancer cachexia.
AI-generated from the title and abstract; the full text is not read.
Key points
- Adipose browning and atrophy are early events in lethal cancer cachexia.
- An iron-dependent pathway involving MSRA activation drives adipose browning.
- Iron stabilizes MSRA by coordinating with its EXXH motif, promoting dimerization and reductase activity.
- Iron-bound MSRA dimers maintain reduced states of substrates, including protein kinase A.
- MsrA deletion in mice impaired adipose browning, mitigated cachexia, and prolonged survival.
AI-generated from the title and abstract; the full text is not read.
Abstract
Abstract Adipose browning and atrophy are early events of cachexia, a lethal metabolic disorder affecting nearly half of the population with cancer. Here, using individual-derived specimens and mouse models, we identified an iron-dependent pathway that initiates adipose browning in both physiological and cachectic settings. Upon adrenergic stimulation of adipocytes, an influx of iron induces the activity of methionine sulfoxide reductase A (MSRA), an enzyme that reverses the oxidation of proteinaceous methionine residues. Mechanistically, iron coordination by the conserved iron-binding EXXH motif of two MSRA polypeptides serves to dimerize, stabilize and elevate its reductase activity. Iron-bound MSRA dimers in turn promote adipose browning by maintaining the reduced state of select substrates, including the catalytic subunit of protein kinase A. Remarkably, in mouse models, MsrA deletion impairs adipose browning, mitigates cachexia and prolongs the survival of tumor-bearing animals. Thus, as a key nexus of cancer-associated cachexia, the β3 adrenergic receptor–iron–MSRA axis is a promising target for clinical intervention.
The authors' abstract, as published at the source. Nature Cancer, 2026 · DOI ↗
The rest is in the Pofolia app
Takeaways and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openBiotechnologyBiochemistry, Genetics and Molecular Biology